CollPlant Biotechnologies (CLGN) Other Non-Current Liabilities (2019 - 2021)
CollPlant Biotechnologies' (CLGN) quarterly Other Non-Current Liabilities came in at -$28000.0 in Q4 2021, down 200.0% YoY from $28000.0 in Q4 2020, and down 200.0% on a QoQ basis from $28000.0 in Q4 2020.
CollPlant Biotechnologies (CLGN) Other Non-Current Liabilities (2019 - 2021) Analysis & Trends
CollPlant Biotechnologies (CLGN) has 3 years of Other Non-Current Liabilities data on file, last reported at -$28000.0 in Q4 2021.
- Quarterly Other Non-Current Liabilities fell 200.0% year-over-year to -$28000.0 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was -$28000.0 (down 200.0% YoY) and the FY2021 annual result came in at -$28000.0, down 200.0% from the prior year.
- Other Non-Current Liabilities fell to -$28000.0 in Q4 2021, from $28000.0 in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $68000.0 in Q4 2019 to a low of -$28000.0 in Q4 2021.
- A 3-year average of $27500.0 and a median of $35000.0 in 2020 frame the typical range for Other Non-Current Liabilities.
- Annual changes were most pronounced in 2020 — Other Non-Current Liabilities slumped 58.82% — and 2021, when it sank 200.0%.
- Tracing CLGN's Other Non-Current Liabilities over 3 years: stood at $68000.0 in 2019, then tumbled by 58.82% to $28000.0 in 2020, then slumped by 200.0% to -$28000.0 in 2021.
- The last three Other Non-Current Liabilities figures came in at -$28000.0 (Q4 2021), $28000.0 (Q4 2020), and $42000.0 (Q2 2020), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | CollPlant Biotechnologies | 4.26 Mn | 4.26 Mn | -243,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -28,000.00 |
| Dec 31, 2020 | 28,000.00 |
| Jun 30, 2020 | 42,000.00 |
| Dec 31, 2019 | 68,000.00 |